Abstract
As SARS-CoV-2 emerged as a global threat in early 2020, China enacted rapid and strict lock-down orders to prevent introductions and suppress transmission. In contrast, the United States federal government did not enact national orders. State and local authorities were left to make rapid decisions based on limited case data and scientific information to protect their communities. To support local decision making in early 2020, we developed a model for estimating the probability of an unseen COVID-19 epidemic in each US county based on the number of confirmed cases. We found that counties with only a single reported case by April 13th had a 50% chance that SARS-CoV-2 was already spreading widely. By that date, 85% of US counties covering 96% of the population had reported at least one case. Given the low rates of testing and reporting early in the pandemic, taking action upon the detection of just one or a few cases may be prudent.
Author Summary By March 28, 2020, only 3 months after the first US case of COVID-19 was detected, COVID-19 emerged in all 50 US states. Officials were forced to weigh the economic and societal costs of strict social distancing measures against the future risks of COVID-19 hospitalizations and mortality in their communities. To support local decision makers throughout the US, we developed a simple model to determine the chance that COVID-19 was spreading unseen based on scant reported case counts. In mid-April, 85% of US counties containing 96% of the population had reported at least one confirmed case. Our model predicted that each of those counties thus faced at least a 50% chance that the virus was already spreading widely. Aggressive pandemic mitigation measures, even before a threat is fully apparent, are particularly critical when testing resources are limited.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We acknowledge the financial support from National Institutes of Health (grant no. U01 GM087719 and project no. 5T32LMO012414).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The MS has been updated to include a retrospective analysis and combine brief report with the supplementary.
Data Availability
Code to generate data available online.
